Citation Impact
Citing Papers
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data
2007 Standout
Safety and efficacy of transaortic renal endarterectomy as an adjunct to aortic surgery
1995
Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias
1990 Standout
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
1998 Standout
The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men
2002 Standout
The Quality of Health Care Delivered to Adults in the United States
2003 Standout
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
2010 Standout
Prognostic implications of left ventricular hypertrophy
2001
Renal-Artery Stenosis
2001 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Exercise Standards for Testing and Training
2013 Standout
Cardiac consequences of renal transplantation: Changes in left ventricular morphology and function
1988
Improved electrocardiographic diagnosis of left ventricular hypertrophy
1994
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Fibromuscular Dysplasia
2004 Standout
Relation of concentric left ventricular hypertrophy and extracardiac target organ damage to supranormal left ventricular performance in established essential hypertension
1988
Endogenous platelet-activating factor and anti-platelet-activating factor in patients with renovascular hypertension
1988
Recommendations for the use of home (self) and ambulatory blood pressure monitoring
1996
Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension
1991 Standout
High-Normal Serum Creatinine Concentration Is a Predictor of Cardiovascular Risk in Essential Hypertension
2001
Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population
2003
Users' Guides to the Medical Literature
2000 Standout
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002 Standout
24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender*
1995
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
Predicting Cardiovascular Risk Using Conventional vs Ambulatory Blood Pressure in Older Patients With Systolic Hypertension
1999
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Obesity and the Risk of Heart Failure
2002 Standout
Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products
1995
Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study
1990 Standout
Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease
1994
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
2004 Standout
Global burden of blood-pressure-related disease, 2001
2008 Standout
The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
1993 Standout
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
2015 Standout
Ambulatory Blood Pressure Is Superior to Clinic Blood Pressure in Predicting Treatment-Induced Regression of Left Ventricular Hypertrophy
1997
Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment
2000 StandoutNobel
Prognostic Value of Ambulatory Blood-Pressure Recordings in Patients with Treated Hypertension
2003
A Prospective Study of Moderate Alcohol Consumption and the Risk of Coronary Disease and Stroke in Women
1988 Standout
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
2002 Standout
Cardiovascular Prognosis of "Masked Hypertension" Detected by Blood Pressure Self-measurement in Elderly Treated Hypertensive Patients
2004
Electrocardiogram in Evaluation of Resistance to Antihypertensive Therapy
1977
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
2003 Standout
Cost-effectiveness of echocardiography and electrocardiography for detection of left ventricular hypertrophy in patients with systemic hypertension.
1987
Femoropopliteal arterial fibrodysplasia
1990
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Cardiovascular Morbidity in Relation to Change in Blood Pressure and Serum Cholesterol Levels in Treated Hypertension
1987
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
2002 Standout
Prognostic Value of Ambulatory Blood Pressure
2000
Fibromuscular dysplasia of the carotid arteries
1986
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Chronic progressive renal disease: Rate of change of serum creatinine concentration
1977
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
2001 Standout
Recommendations concerning use of echocardiography in hypertension and general population research.
1987
Risk factors for subarachnoid hemorrhage.
1985
Regional cerebral blood flow correlates of aphasia outcome in cerebral hemorrhage and cerebral infarction.
1986 StandoutNobel
Human blood pressure determination by sphygmomanometry.
1993
Putative mechanism of hypotensive action of platelet-activating factor in dogs.
1992 StandoutNobel
MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis
1991 Standout
Surgical Treatment of Renovascular Hypertension in the Pediatric Patient
1978
Prediction of Cardiac Structure and Function by Repeated Clinic and Ambulatory Blood Pressure
1997
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Impact of Aortic Stiffness on Survival in End-Stage Renal Disease
1999 Standout
Treatment-Induced Blood Pressure Reduction and the Risk of Myocardial Infarction
1989
Essential Hypertension
1966
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
2008 Standout
In vivo measurement of myocardial mass using nuclear magnetic resonance imaging
1986
Prognostic Value of Ambulatory Blood Pressure Monitoring in Refractory Hypertension
1998
Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus
2015
Response to Antihypertensive Therapy in Older Patients With Sustained and Nonsustained Systolic Hypertension
2000
Blood pressure, stroke, and coronary heart disease
1990 Standout
Aphasia outcome in stroke: a clinical neuroradiological correlation.
1976
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.
1977 Standout
Global Burden of Cardiovascular Diseases
2001 Standout
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
Ambulatory blood pressure monitoring and 24-h blood pressure control as predictors of outcome in treated hypertensive patients
2001
Clinical Characteristics of Renovascular Hypertension
1972
Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults
1988
Electrocardiographic detection of left ventricular hypertrophy using echocardiographic determination of left ventricular mass as the reference standard
1984
Renovascular Hypertension Secondary to Arterial Fibrodysplasia in Adults
1975
The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension
1986
Fibromuscular Dysplasia of the Internal Carotid Arteries
1981
FIBROMUSCULAR DYSPLASIA OF THE CAROTID ARTERY
1983
Standardization of M-mode echocardiographic left ventricular anatomic measurements
1984
Utility of blood pressure monitoring outside of the clinic setting.
2002
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
1999 Standout
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2005 Standout
Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension.
1994
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002 Standout
A pathologic-arteriographic correlation of renal arterial disease
1966
Value of Echocardiographic Measurement of Left Ventricular Mass in Predicting Cardiovascular Morbid Events in Hypertensive Men
1986
Dietary Protein Intake and the Progressive Nature of Kidney Disease:
1982 Standout
Exercise Blood Pressure Predicts Mortality From Myocardial Infarction
1996
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of D Perloff being referenced
Prognostic value of ambulatory blood pressure measurements: further analyses.
1989
Ambulatory blood pressure monitoring
1994
Blood Pressure Variability and Its Implications for Antihypertensive Therapy
1995
Autogenous Tissue Revascularization Technics in Surgery for Renovascular Hypertension
1969
7 Renovascular hypertension
1981
Five year survival of consecutive patients with malignant hypertension treated with antihypertensive agents
1960
FIBROMUSCULAR HYPERPLASIA
1966
The prognostic value of ambulatory blood pressure monitoring in treated hypertensive patients.
1991
Ambulatory blood pressure: the San Francisco experience.
1990
The Prognosis of Essential Hypertension Treated Conservatively
1961
Hypertension Secondary to Renal Artery Occlusive Disease
1961